Not all cancer drugs are living up to their hype.
There are more new drugs to treat cancer than ever before, but in some cases, they may not live up to their promise
But in an article published in the BMJ, scientists argue that some vaunted cancer medications aren’t living up to their promises to save more patients’ lives.
The reason has to do with the many ethically questionable practices throughout the drug-development process, says Peter Wise, retired from Charing Cross Hospital and Imperial College School of Medicine in London. These practices range from research by pharmaceutical companies to the way new compounds are tested, how data is interpreted, to the approval process by regulatory agencies and the way that doctors are incentivized to prescribe them. “There are different layers in the whole process and real problems all the way down the line,” he says.
Read Full Article: Why the Latest Cancer Drugs May Not Be as Successful as They Seem | TIME
|Read Full Article: Why the Latest Cancer Drugs May Not Be as Successful as They Seem | TIME|